Real-time enrollment status for this growth hormone deficiency (ghd) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 1:40 AM UTC
| NCT Number | NCT06948214 |
| Recruiting Status | Recruiting |
| Condition | Growth Hormone Deficiency (GHD) |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Lumos Pharma |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06948214 is currently recruiting participants. This phase3 study for growth hormone deficiency (ghd) is actively seeking new participants at 29 locations across the United States. The study is sponsored by Lumos Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06948214 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06948214 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.